Codon Capital brings entrepreneurs and researchers to discover strategies for translating innovation into products and startup companies.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Codon Capital is a venture capital firm that brings entrepreneurs and researchers to discover strategies for translating innovation into products and startup companies. It focuses on two biology disciplines, Therapeutics and Synthetic Biology, each with unique investment benefits. Together, they represent the new biology design revolution, opportunities that will define healthcare, and agriculture. Founded in 2013 by Karl Handelsman, Codon Capital is headquartered in San Francisco, California.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2022 | Bonum | Series A | 93M |
4/2022 | Ansa Biotechnologies | Series A | 68M |
5/2020 | Good Therapeutics | Series A | 0 |
4/2020 | Pivot Bio | Series C | 0 |
4/2022 | Ansa Biotechnologies | Series A | 0 |
5/2020 | Good Therapeutics | Series A | 0 |
4/2020 | Pivot Bio | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|